Two studies show that specific cullin-RING E3 ubiquitin ligases can be targeted with small molecules.
References
Soucy, T.A. et al. Nature 458, 732–736 (2009).
Orlicky, S. et al. Nat. Biotechnol. 28, 733–737 (2010).
Aghajan, M. et al. Nat. Biotechnol. 28, 738–742 (2010).
Petroski, M.D. & Deshaies, R.J. Nat. Rev. Mol. Cell Biol. 6, 9–20 (2005).
Nash, P. et al. Nature 414, 514–521 (2001).
Hao, B., Oehlmann, S., Sowa, M.E., Harper, J.W. & Pavletich, N.P. Mol. Cell 26, 131–143 (2007).
Welcker, M. & Clurman, B.E. Nat. Rev. Cancer 8, 83–93 (2008).
Nalepa, G., Rolfe, M. & Harper, J.W. Nat. Rev. Drug Discov. 5, 596–613 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lydeard, J., Harper, J. Inhibitors for E3 ubiquitin ligases. Nat Biotechnol 28, 682–684 (2010). https://doi.org/10.1038/nbt0710-682
Issue Date:
DOI: https://doi.org/10.1038/nbt0710-682
- Springer Nature America, Inc.
This article is cited by
-
Surface charge of Merkel cell polyomavirus small T antigen determines cell transformation through allosteric FBW7 WD40 domain targeting
Oncogenesis (2020)
-
c-CBL E3 Ubiquitin Ligase Is Overexpressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation-Induced Cell Death
Journal of Investigative Dermatology (2015)
-
Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis
Journal of Computer-Aided Molecular Design (2014)
-
Inhibiting E3 ligases
Science-Business eXchange (2010)